Treatment of Moderate to Severe Refractory Crohn's Disease

Recruiting

Phase 1

Phase 2

Treatment of Crohn'sTreatment of Moderate to Severe Refractory Crohn's Disease

Sponsor:

Tr1X, Inc.

Code:

NCT06721962

Conditions

Crohns Disease

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

TRX103

Cyclophosphamide

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-14. This information was provided to ClinicalTrials.gov by Tr1X, Inc. on 2025-07-11.